Bill removes risk of wrongful DUI arrest for medical cannabis patients
Marijuana Industry NewsPennsylvania June 29, 2022 MJ Shareholders 0
Legislation that would protect Pennsylvania’s more than 700,000 medical marijuana patients from wrongful driving under the influence convictions advanced out of the Senate Transportation Committee on Tuesday by a 13-0 vote.
The bill would treat medical cannabis like any other prescription narcotic. It would require proof of impairment that interferes with a person’s ability to safely operate a motor vehicle for them to be charged with DUI.
It now will advance to the Senate for consideration.
Sen. Camera Bartolotta, R-Washington County, the bill’s sponsor, said Pennsylvania’s zero tolerance DUI law currently creates the possibility for medical cannabis patients to be arrested, prosecuted and convicted for taking their medicine while driving, even if they’re not impaired. She called it the most serious issue facing the state’s medical cannabis patients.
“Senate Bill 167 is critically needed to protect the medical cannabis community as the penalties for a controlled substance significantly escalate,” she told the committee.
Criminal defense lawyer Patrick Nightingale from Pittsburgh told the committee medical cannabis users are at risk of losing their licenses or even being jailed, at a hearing last September.
“We’re only three years into this [medical marijuana] program and these patients presumably are going to be using medical cannabis for the rest of their lives,” he said. “They’re going to have a number two DUI come up pretty soon and a number three DUI where they are looking at a year incarceration for using medication that the state said is 100% fine to use.” [Read More @ Penn Live]
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.